Back to search

Spain· ES:34411

VASELINA PURA REIG JOFRE POMADA

A medicinal product containing parafina blanda (vaselina filante), registered in Spain by Laboratorio Reig Jofre, S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedVASELINA PURA REIG JOFRE POMADAATC—REGISTER NO.ES:34411PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
parafina blanda (vaselina filante)
Manufacturer
Laboratorio Reig Jofre, S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Parafina blanda (vaselina filante) in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All parafina blanda (vaselina filante) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0818f545-4535-4e75-a610-d0c5f9d59fa9
GET /v1/drugs/0818f545-4535-4e75-a610-d0c5f9d59fa9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Sin Receta",
  "estado": "{\"aut\":-294541200000}",
  "nregistro": "34411",
  "substance": "parafina blanda (vaselina filante)"
}

See everything about parafina blanda (vaselina filante).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.